These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21177296)

  • 1. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort.
    Durnez A; Vanderschueren G; Lateur L; Westhovens R; Verschueren P
    Ann Rheum Dis; 2011 Apr; 70(4):634-7. PubMed ID: 21177296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.
    Visser K; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Ronday HK; Seys PE; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2010 Jul; 69(7):1333-7. PubMed ID: 20498212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice.
    De Cock D; Vanderschueren G; Meyfroidt S; Joly J; Westhovens R; Verschueren P
    Clin Rheumatol; 2014 Jan; 33(1):125-30. PubMed ID: 24077951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Vastesaeger N; Xu S; Aletaha D; St Clair EW; Smolen JS
    Rheumatology (Oxford); 2009 Sep; 48(9):1114-21. PubMed ID: 19589891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of matrices in daily clinical practice to predict rapid radiologic progression in patients with early RA.
    De Cock D; Vanderschueren G; Meyfroidt S; Joly J; Van der Elst K; Westhovens R; Verschueren P
    Semin Arthritis Rheum; 2014 Apr; 43(5):627-31. PubMed ID: 24200124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.
    Fautrel B; Granger B; Combe B; Saraux A; Guillemin F; Le Loet X
    Arthritis Res Ther; 2012 Nov; 14(6):R249. PubMed ID: 23164197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.
    Rydell E; Forslind K; Nilsson JÅ; Jacobsson LTH; Turesson C
    Arthritis Res Ther; 2018 May; 20(1):82. PubMed ID: 29720260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
    Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
    J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients.
    Végh E; Gaál J; Géher P; Gömöri E; Kovács A; Kovács L; Nagy K; Posta EF; Tamási L; Tóth E; Varga E; Domján A; Szekanecz Z; Szűcs G
    BMC Musculoskelet Disord; 2021 Apr; 22(1):325. PubMed ID: 33794855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?
    Heimans L; Wevers-deBoer KV; Ronday HK; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Clin Rheumatol; 2015 Jan; 34(1):163-6. PubMed ID: 25431327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
    Hetland ML; Stengaard-Pedersen K; Junker P; Østergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Hørslev-Petersen K;
    Ann Rheum Dis; 2010 Oct; 69(10):1789-95. PubMed ID: 20444751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients: pooled analyses from several databases.
    Vanier A; Smolen JS; Allaart CF; Van Vollenhoven R; Verschueren P; Vastesaeger N; Saevarsdottir S; Visser K; Aletaha D; Combe B; Fautrel B
    Rheumatology (Oxford); 2020 Aug; 59(8):1842-1852. PubMed ID: 31722413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
    Ellingsen T; Hansen I; Thorsen J; Møller BK; Tarp U; Lottenburger T; Andersen LS; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Lindegaard H; Jacobsen S; Østergaard M; Vestergaard A; Jurik AG; Junker P; Christensen AF; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K
    Scand J Rheumatol; 2014; 43(2):91-100. PubMed ID: 23980529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
    Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.
    Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S126-35. PubMed ID: 18240203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.
    Lillegraven S; Paynter N; Prince FH; Shadick NA; Haavardsholm EA; Frits ML; Iannaccone CK; Kvien TK; Weinblatt ME; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Apr; 65(4):526-33. PubMed ID: 23044765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
    Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
    Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.
    van den Broek M; Dirven L; de Vries-Bouwstra JK; Dehpoor AJ; Goekoop-Ruiterman YP; Gerards AH; Kerstens PJ; Huizinga TW; Lems W; Allaart CF
    Ann Rheum Dis; 2012 Sep; 71(9):1530-3. PubMed ID: 22532630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study.
    Hafström I; Albertsson K; Boonen A; van der Heijde D; Landewé R; Svensson B;
    Ann Rheum Dis; 2009 Apr; 68(4):508-13. PubMed ID: 18420939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.